MarginsXMarginsX
Home › Markets › Health Care › HROW

Harrow Inc. (HROW)

HROW trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$29.09
-3.42% on the day
Market cap
$1.1B
Small cap
Revenue · 2025
$272.3M
+36.4% on 2024
Net income · 2025
-$5.1M
-1.9% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1360214/000149315226008562/0001493152-26-008562-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerHROW on Nasdaq
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryUnited States
IPO yearNot reported by the screener
SEC CIK0001360214
SEC industry codePharmaceutical Preparations
Incorporated inDE

Financials · 2025

LineValue
Revenue$272.3M
Net income-$5.1M
Operating income$30.5M
Net margin-1.9%
Operating margin11.2%
Revenue growth+36.4%
Cash$72.9M
Total assets$399.5M
P/E (computed)Net income was not positive
P/S (computed)4.0×

Warning signs

Cash runway
47.7 months
$75.3M cash at September 30, 2026
Share count, 1 year
+1.3%
2025-11-10 to 2026-11-05 · +6.9% over 3 years
Going-concern doubt
No
10-Q filed November 9, 2026
Insider net buying, 12 months
-$9.2M
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-11-09
Cash and burn$75.3M cash; operating cash flow -$4.7M a quarter.Report 2026-09-30
Shares outstanding37,533,160 (2026-11-05); 37,037,453 a year earlier; 35,117,746 three years earlier.Cover page 2026-11-05
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
Delisting25-NSE filed25-NSE 2025-10-10
AuditorDeloitte & Touche LLP, Nashville, Tennessee, United States; changed auditors 1 time in 24 months8-K 4.01 2025-09-19
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $469K, sold $9.6M on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$99.3M$9.8M-$8.6M$75.3MNo debt tags$303.3M10-Q 2026-11-09
Q2 2026
2026-06-30
$70.7M-$17.3M-$9.8M$83.9MNo debt tags$275.6M10-Q 2026-08-10
Q1 2026
2026-03-31
$44.2M-$27.6M-$9.0M$94.6M$300.0M$268.7M10-Q 2026-05-11
Q4 2025
2025-12-31
$89.1M$6.6M$8.4M$72.9M$250.0M$272.3M10-K 2026-03-02
Q3 2025
2025-09-30
$71.6M$1.0M$16.6M$74.3M$347.2M$250.0M10-Q 2026-11-09
Q2 2025
2025-06-30
$63.7M$5.0M-$803K$53.0M$250.6M$227.7M10-Q 2026-08-10
Q1 2025
2025-03-31
$47.8M-$17.8M$19.7M$66.7M$256.9M$212.9M10-Q 2026-05-11
Q4 2024
2024-12-31
$66.8M$6.8M-$17.8M$47.2M$262.7M$199.6M10-K 2026-03-02

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B52023-07-19
Latest annual report10-K2026-03-02
Latest quarterly / interim10-Q2026-11-09
Latest current report8-K2026-11-16
Latest proxyDEFA14A2026-04-24

Source: SEC EDGAR submissions feed, 873 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+12.0%
1 month+6.7%
3 months-22.5%
Year to date-38.5%
1 year-20.5%
From 52-week high-45.0%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
ANROAlto Neuroscience Inc.$27.12-8.19%$1.1B
MTRIMentari Therapeutics Inc.$19.87+6.83%$1.0B
SPTXSeaport Therapeutics Inc.$19.12-4.30%$1.0B
CMPSCOMPASS Pathways Plc American Depository Shares$8.27-8.21%$1.2B
CYRXCryoPort Inc.$19.80-0.45%$1.0B
MLTXMoonLake Immunotherapeutics$11.73-6.16%$998.3M
KARDKardigan Inc.$12.85-7.02%$1.2B
OPKOPKO Health Inc.$1.62-3.57%$1.2B

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier